These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1304 related articles for article (PubMed ID: 9351494)

  • 21. Dopamine D2 receptor-mediated G protein activation assessed by agonist-stimulated [35S]guanosine 5'-O-(gamma-thiotriphosphate) binding in rat striatal membranes.
    Odagaki Y; Toyoshima R
    Prog Neuropsychopharmacol Biol Psychiatry; 2006 Sep; 30(7):1304-12. PubMed ID: 16824659
    [TBL] [Abstract][Full Text] [Related]  

  • 22. An agonist that is selective for adenylate cyclase-coupled muscarinic receptors.
    Baumgold J; Drobnick A
    Mol Pharmacol; 1989 Sep; 36(3):465-70. PubMed ID: 2550780
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Interactions of agonists with M2 and M4 muscarinic receptor subtypes mediating cyclic AMP inhibition.
    McKinney M; Miller JH; Gibson VA; Nickelson L; Aksoy S
    Mol Pharmacol; 1991 Dec; 40(6):1014-22. PubMed ID: 1722002
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Inverse agonists and neutral antagonists of recombinant human A1 adenosine receptors stably expressed in Chinese hamster ovary cells.
    Shryock JC; Ozeck MJ; Belardinelli L
    Mol Pharmacol; 1998 May; 53(5):886-93. PubMed ID: 9584215
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pharmacological coupling and functional role for the muscarinic receptor subtypes in isolated cells from the circular smooth muscle of the rabbit cecum.
    Cuq P; Magous R; Bali JP
    J Pharmacol Exp Ther; 1994 Oct; 271(1):149-55. PubMed ID: 7965708
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Expression of functional muscarinic acetylcholine receptor subtypes in human corpus cavernosum and in cultured smooth muscle cells.
    Traish AM; Palmer MS; Goldstein I; Moreland RB
    Receptor; 1995; 5(3):159-76. PubMed ID: 8729195
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Characterization of dopamine receptors mediating inhibition of adenylate cyclase activity in rat striatum.
    Onali P; Olianas MC; Gessa GL
    Mol Pharmacol; 1985 Aug; 28(2):138-45. PubMed ID: 2410769
    [TBL] [Abstract][Full Text] [Related]  

  • 28. BW373U86: a nonpeptidic delta-opioid agonist with novel receptor-G protein-mediated actions in rat brain membranes and neuroblastoma cells.
    Childers SR; Fleming LM; Selley DE; McNutt RW; Chang KJ
    Mol Pharmacol; 1993 Oct; 44(4):827-34. PubMed ID: 8232233
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Characterization of the G protein involved in the muscarinic stimulation of adenylyl cyclase of rat olfactory bulb.
    Olianas MC; Onali P
    Mol Pharmacol; 1996 Jan; 49(1):22-9. PubMed ID: 8569708
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Differential coupling of m1, m2 and m3 muscarinic receptor subtypes to inositol 1,4,5-trisphosphate and adenosine 3',5'-cyclic monophosphate accumulation in Chinese hamster ovary cells.
    Burford NT; Tobin AB; Nahorski SR
    J Pharmacol Exp Ther; 1995 Jul; 274(1):134-42. PubMed ID: 7616390
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The interaction of the enantiomers of aceclidine with subtypes of the muscarinic receptor.
    Ehlert FJ; Griffin MT; Glidden PF
    J Pharmacol Exp Ther; 1996 Dec; 279(3):1335-44. PubMed ID: 8968358
    [TBL] [Abstract][Full Text] [Related]  

  • 32. In vitro characterization of SLV308 (7-[4-methyl-1-piperazinyl]-2(3H)-benzoxazolone, monohydrochloride): a novel partial dopamine D2 and D3 receptor agonist and serotonin 5-HT1A receptor agonist.
    Glennon JC; Van Scharrenburg G; Ronken E; Hesselink MB; Reinders JH; Van Der Neut M; Long SK; Feenstra RW; McCreary AC
    Synapse; 2006 Dec; 60(8):599-608. PubMed ID: 17001660
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The muscarinic M(4) receptor is the functionally predominant subtype in rat and mouse striatum as demonstrated using [(35)S] GTPγS binding.
    Chapman KL; Vaswani D; Hendry N; Langmead CJ; Kew JN; Watson JM
    Eur J Pharmacol; 2011 Feb; 652(1-3):1-6. PubMed ID: 21114972
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of (-)-RO363 at human atrial beta-adrenoceptor subtypes, the human cloned beta 3-adrenoceptor and rodent intestinal beta 3-adrenoceptors.
    Molenaar P; Sarsero D; Arch JR; Kelly J; Henson SM; Kaumann AJ
    Br J Pharmacol; 1997 Jan; 120(2):165-76. PubMed ID: 9117106
    [TBL] [Abstract][Full Text] [Related]  

  • 35. CI-1007, a dopamine partial agonist and potential antipsychotic agent. I. Neurochemical effects.
    Rugsley TA; Davis MD; Akunne HC; Cooke LW; Whetzel SZ; MacKenzie RG; Shih YH; van Leeuwen DH; DeMattos SB; Georgic LM
    J Pharmacol Exp Ther; 1995 Aug; 274(2):898-911. PubMed ID: 7636753
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of acetylethylcholine mustard on muscarinic receptor-coupled attenuation of cAMP formation in intact GH3 cells.
    Bolden CP; Baker SP
    J Pharmacol Exp Ther; 1990 Jul; 254(1):136-41. PubMed ID: 2164088
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Impairment of muscarinic stimulation of adenylyl cyclase by heparin in rat olfactory bulb.
    Olianas MC; Onali P
    Life Sci; 1997; 61(5):515-22. PubMed ID: 9247321
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The agonist activities of the putative antipsychotic agents, L-745,870 and U-101958 in HEK293 cells expressing the human dopamine D4.4 receptor.
    Gazi L; Bobirnac I; Danzeisen M; Schüpbach E; Bruinvels AT; Geisse S; Sommer B; Hoyer D; Tricklebank M; Schoeffter P
    Br J Pharmacol; 1998 Jul; 124(5):889-96. PubMed ID: 9692773
    [TBL] [Abstract][Full Text] [Related]  

  • 39. In vitro effect of chlorpyrifos oxon on muscarinic receptors and adenylate cyclase.
    Huff RA; Abou-Donia MB
    Neurotoxicology; 1995; 16(2):281-90. PubMed ID: 7566687
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Adenosine A1 receptor-dependent and -independent effects of the allosteric enhancer PD 81,723.
    Musser B; Mudumbi RV; Liu J; Olson RD; Vestal RE
    J Pharmacol Exp Ther; 1999 Feb; 288(2):446-54. PubMed ID: 9918544
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 66.